We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

MorphoSys Signs Long-term Alliance with Pfizer on Sloning Technology Platform

News   Dec 12, 2010

 
MorphoSys Signs Long-term Alliance with Pfizer on Sloning Technology Platform
 
 
 

RELATED ARTICLES

Ancient Enzymes the Catalysts for Discoveries

News

University of Queensland-led research recreating 450 million-year-old enzymes has resulted in a biochemical engineering ‘hack’ which could lead to new drugs, flavours, fragrances and biofuels.

READ MORE

Structure Discovered Which Mediates Cell-matrix Attachment During Mitosis

News

The newly discovered adhesion complex can provide answers to an as-yet unanswered question – how the cell can remain attached to the matrix during cell division.

READ MORE

Tracking Down Missing-in-Action Multiple Sclerosis Genes

News

Previous work by the International Multiple Sclerosis Genetics Consortium (IMSGC) has identified 233 genetic risk variants. However, these only account for about 20% of overall disease risk, with the remaining genetic culprits proving elusive. A new study has tracked down four of these hard-to-find genes.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE